HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
🗨️ “𝐼𝑡’𝑠 𝑎𝑏𝑜𝑢𝑡 𝑐𝑟𝑒𝑎𝑡𝑖𝑛𝑔 𝑎 𝑚𝑢𝑡𝑢𝑎𝑙𝑙𝑦 𝑏𝑒𝑛𝑒𝑓𝑖𝑐𝑖𝑎𝑙 𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛𝑠ℎ𝑖𝑝 𝑤𝑖𝑡ℎ 𝐾𝑜𝑟𝑒𝑎𝑛 𝑐𝑢𝑠𝑡𝑜𝑚𝑒𝑟𝑠. 𝑊𝑒 𝑤𝑖𝑙𝑙 𝑎𝑐𝑡𝑖𝑣𝑒𝑙𝑦 𝑠𝑢𝑝𝑝𝑜𝑟𝑡 𝐾𝑜𝑟𝑒𝑎𝑛 𝑐𝑜𝑚𝑝𝑎𝑛𝑖𝑒𝑠 𝑠𝑜 𝑡ℎ𝑎𝑡 𝑡ℎ𝑒𝑦 𝑐𝑎𝑛 𝑏𝑒 𝑎𝑐𝑡𝑖𝑣𝑒 𝑛𝑜𝑡 𝑜𝑛𝑙𝑦 𝑜𝑛 𝑡ℎ𝑒 𝐾𝑜𝑟𝑒𝑎𝑛 𝑚𝑎𝑟𝑘𝑒𝑡, 𝑏𝑢𝑡 𝑎𝑙𝑠𝑜 𝑜𝑛 𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑚𝑎𝑟𝑘𝑒𝑡𝑠.”
📎 For Korean speakers, read the full article here by clicking this link
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.